Efficacy of Nalbuphine and Naloxone Administered as Nose Sprays in the Treatment of Orofacial Pain
This study is currently recruiting participants.
Verified by University of California, San Francisc READ MORE http://clinicaltrials.gov/ct2/show/NCT00716807...
Burning Mouth Disorder (BMD) - A Neuropathic Pain Disorder
This study is currently recruiting participants.
Verified by Charite University, Berlin, Germany, March 2009
First Received: July 19, 2007 READ MORE http://clinicaltrials.gov/ct2/show/NCT00504387...
Neurogenic Mechanisms in Burning Mouth Syndrome (BMS17)
This study is currently recruiting participants.
Verified by University of Copenhagen, April 2009
First Received: April 2, 2009 No Change READ MORE http://www.clinicaltrials.gov/ct2/show/NCT00875537...
Burning Mouth Disorder (BMD) - A Neuropathic Pain Disorder
This study is currently recruiting participants.
Verified by Charite University, Berlin, Germany, May 2008
Sponsors and Collaborators: READ MORE http://clinicaltrials.gov/ct2/show/NCT00504387
Objective: Burning mouth syndrome (BMS) is an orofacial pain disorder characterized by a chronic, idiopathic burning sensation of the oral mucosa that mostly affects middle-aged women. Although both p READ MORE http://www.ncbi.nlm.nih.gov/pubmed/18764838...
BACKGROUND: Burning mouth disorder (BMD) is a burning or stinging sensation affecting the oral mucosa, lips, and/or tongue, in the absence of clinically visible mucosal lesions. There is a strong fema READ MORE http://www.ncbi.nlm.nih.gov/pubmed/18667977...
OBJECTIVE: To study the quality of life in patients with burning mouth syndrome (BMS), our primary aim was to compare BMS patients with healthy controls and the secondary aim was to compare subgroups READ MORE http://www.ncbi.nlm.nih.gov/pubmed/18665968...
OBJECTIVE: The objective of this study was to evaluate the effectiveness and tolerability of paroxetine in patients with burning mouth syndrome (BMS). DESIGN: In a 12-week open-label, noncomparative, READ MORE http://www.ncbi.nlm.nih.gov/pubmed/18996028...
Efficacy of alpha lipoic acid in burning mouth syndrome: a randomized, placebo-treatment study
To study the efficacy of alpha lipoic acid (ALA) in a group of patients with burning mouth syndrome (BMS READ MORE http://www.ncbi.nlm.nih.gov/pubmed/18976257...
Burning mouth syndrome (BMS) is characterized by oral burning or similar pain in the absence of detectable oral mucosa changes. This condition is more common among middle-aged and elderly women. Altho READ MORE http://www.ncbi.nlm.nih.gov/pubmed/18985004...